HR 2521 · 112th Congress 2011–2013, ended

Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011

Latest action · Jul 15, 2011 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 13, 2011
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 - Requires the Director of the National Institute of Environmental Health Sciences, as part of the National Toxicology Program, to: (1) establish and implement a research program designed to strengthen the scientific basis of information used by federal agencies to understand the effects of, and reduce human exposure to, endocrine-disrupting chemicals; (2) establish an Endocrine Disruption Expert Panel to report to the Director on issues related to identification, classification, or evaluation of endocrine-disrupting chemicals; (3) for each chemical determined by the Director to be a potential or actual endocrine-disrupting chemical, identify the level of evidence that such chemical is or may be an endocrine-disrupting chemical, the level of concern that such chemical may disrupt the human endocrine system, and the pathways of exposure to the chemical for humans and animals; and (4) provide to Congress and each relevant federal agency and make publicly available every two years an up-to-date list of potential or actual endocrine-disrupting chemicals and a report on the Program's activities and on federal agencies' activities with respect to endocrine-disrupting chemicals.

Requires the Panel to: (1) report to the Director on issues related to identification, classification, or evaluation of not more than 10 endocrine-disrupting chemicals or groups of chemicals; (2) evaluate existing research aimed at understanding the biological pathways in humans by which such chemicals operate and identify future research priorities; and (3) maintain a list that identifies chemicals of concern for endocrine disruption effects.

Authorizes any state, tribe, local government, federal agency, or person to petition the Director to: (1) determine whether a chemical should be identified by the Program as a potential or actual endocrine-disrupting chemical and included in the list; or (2) reclassify a chemical, revise a finding, or amend any other determination of the Program based upon new information. Provides that a listing, finding, or other determination shall not be subject to judicial review or to correction under the Information Quality Act.

Amends the Public Health Service Act to require the Director to conduct and support an Endocrine Disruption Research Program. Authorizes the Director to conduct workshops and fora and provide information on the health effects associated with chemicals that may disrupt the endocrine system.

Requires each federal agency with regulatory authority over any chemical included on the list to prepare and publish a written response to each biennial list. Specifies actions each such agency must take if: (1) the Director determines there is a minimal level of concern that a chemical may disrupt the human endocrine system (e.g., developing a strategy for reducing human exposure to the chemical, including methods to promote voluntary actions by industry for reducing such exposure), and (2) the Director determines there is a high level of concern (e.g., prohibiting the use of the chemical in a manner in or affecting interstate commerce unless the pathway to human exposure is mitigated before or in conjunction with such use). Provides for citizen suits to restrain the prohibited use of chemicals under this Act.

Requires: (1) the Administrator of the Environmental Protection Agency (EPA) to include findings and determinations of the Program in the Aggregated Computational Toxicology Resource databases to the extent permitted by law, and (2) the Director to establish a program to support graduate and postdoctoral training in fields related to the study and prevention of endocrine disruption.

Cosponsors 14

Members who signed on, in the order they did. Signatures ran from Jul 13, 2011 to Sep 7, 2011; 12 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-ILBobby L. RushOriginalJul 13, 2011
D-NCDavid E. PriceOriginalJul 13, 2011
D-DCEleanor Holmes NortonOriginalJul 13, 2011
D-CAGeorge MillerOriginalJul 13, 2011
D-VAGerald E. ConnollyOriginalJul 13, 2011
D-MAJames P. McGovernOriginalJul 13, 2011
D-ILJanice D. SchakowskyOriginalJul 13, 2011
D-CALaura RichardsonOriginalJul 13, 2011
D-CALois CappsOriginalJul 13, 2011
D-NYMaurice D. HincheyOriginalJul 13, 2011
D-NYNita M. LoweyOriginalJul 13, 2011
D-AZRaúl M. GrijalvaOriginalJul 13, 2011
D-OREarl BlumenauerJul 14, 2011
D-NJSteven R. RothmanSep 7, 2011

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jul 13, 2011
Health Subcommittee
Referred Jul 15, 2011

Actions 4

Everything that happened, newest first.

  1. Jul 15, 2011Referred to the Subcommittee on Health.
  2. Jul 13, 2011Introduced in House
  3. Jul 13, 2011Sponsor introductory remarks on measure. (CR E1311-1312)
  4. Jul 13, 2011Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
ExtensionsDebate and remarks E1311James P. Moran D-VAJul 13, 2011

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: This Bill is enacted pursuant to Article I, Section 8 of the United States Constitution, which provides that the Congress shall have Power: ``To regulate Commerce . . . among the several States, and with the Indian Tribes;'' and ``To make all Laws which shall be necessary and proper for carrying into Execution the foregoing Powers, and all other Powers vested by the Constitution in the Government of the United States, or in any Department or Officer thereof.

The sponsor’s statement, as printed in the page H5019.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1361Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011Related billJul 13, 2011

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To reduce human exposure to endocrine-disrupting chemicals, and for other purposes.
Short Titles as Introduced
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 13, 2011Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.